NCT06101966View on ClinicalTrials.gov

A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions

Cervical CancerRadiotherapyDistant MetastasisPrognostic ModelRisk Factor

Interventions

RADIATION

external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)

Radical RT consisted of external pelvic beam radiotherapy (EBRT) and individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT).Cisplatin-based concurrent chemoradiotherapy (CCRT) was recommended for CC patients unless for economic status, age consideration and patients' desires.

Trial Locations (1)

350014

Fujian Cancer Hospital, Fuzhou

All Listed Sponsors

lead

Fujian Cancer Hospital

OTHER_GOV

NCT06101966 - A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy | Biotech Hunter | Biotech Hunter